Lung cancer (LC) is the most common cancer-related death globally, and many efforts have
been made to improve the patient care of LC patients, as well as the development of efficient …

Lung cancer is the most devastating malignancy in the world. Beyond genetic research,
epigenomic studies—especially investigations of microRNAs—have grown rapidly in …

Simple Summary Despite an initial response to therapy, many lung cancer patients
inevitably develop resistance to therapy leading to decreased duration of response and …

Ovarian cancer (OC) is characterized by frequent widespread peritoneal metastasis. Cancer‐
associated fibroblasts (CAFs) represent a critical stromal component of metastatic niche and …

Prostate cancer (PCa) accounts for a high number of deaths in males with no available
curative treatments. Patients with PCa are commonly diagnosed in advanced stages due to …

Effectively targeting cancer stem cells, a subpopulation of tumorigenic, aggressive, and
radioresistant cells, holds therapeutic promise. However, the effects of the microRNA miR …

Temozolomide (TMZ) is the most commonly used alkylating agent in glioma chemotherapy.
However, growing resistance to TMZ remains a major challenge for clinicians. Recent …

Radiotherapy (RT) is considered as a standard in the treatment of most solid cancers,
including glioblastoma, lung, breast, rectal, prostate, colorectal, cervical, esophageal, and …

Lung cancer (LC) is one of the leading causes of cancer‐related death in the world. miR‐24‐
3p plays critical roles in many cancer types, including LC. In this study, we first investigated …

Abstract miR‐29 family is one of the small noncoding RNAs and has a very important role in
many physiologic and pathologic functions through regulating the target genes that play …